Shivani Chib | Pharmacology, Toxicology and Pharmaceutical Science | Women Researcher Award

Ms. Shivani Chib | Pharmacology, Toxicology and Pharmaceutical Science | Women Researcher Award

Central University of Punjab | India

Ms. Shivani Chib is an emerging researcher in the field of pharmacology, specializing in neurodegenerative diseases with a particular focus on Parkinson’s disease and the therapeutic potential of phytoconstituents. Currently pursuing her Ph.D. at the Central University of Punjab, Bathinda, she has contributed extensively through high-impact publications, innovative patents, international presentations, and active peer-reviewing for reputed journals. With multiple national and international awards, she stands out as a dedicated woman researcher committed to advancing pharmacological science and drug discovery.

Professional Profile

Scopus

Google Scholar

Education

Ms. Shivani Chib is currently pursuing her doctoral research in Pharmacology at the Central University of Punjab, Bathinda, under the guidance of Dr. Randhir Singh. Her Ph.D. research centers on Parkinson’s disease and the therapeutic potential of bioactive phytoconstituents, reflecting her dedication to translational research in neuropharmacology. Before her doctoral studies, she completed her Master of Pharmacy in Pharmacology from ISF College of Pharmacy, where she excelled academically and carried out research in experimental pharmacology. Her academic journey began with a Bachelor of Pharmacy in Pharmaceutical Sciences from Sri Sai College of Pharmacy. This progression in higher education reflects not only her intellectual growth but also her determination to specialize in pharmacology and contribute to the field of neuroscience.

Experience

Her professional journey as a researcher began during her postgraduate studies, where she worked as a Research Scholar and focused on understanding drug mechanisms and neuroprotective agents. Currently, as a Ph.D. Research Scholar at the Central University of Punjab, she is engaged in cutting-edge research on Parkinson’s disease, with particular emphasis on dopaminergic neuronal death and the role of phytochemicals such as luteolin and wogonin. She has also contributed as a reviewer for multiple Springer Nature journals, a role that reflects her expertise and recognition in the scientific community. Her active engagement in national and international conferences, combined with her innovative experimental approaches, illustrates her wide-ranging experience in both research and academic settings.

Research Interest

Her research interests revolve around neuropharmacology, neurodegenerative disorders, natural product-based drug discovery, and cognitive impairments associated with aging. She has a deep focus on elucidating the mechanisms of dopaminergic neuronal death in Parkinson’s disease and identifying bioactive phytoconstituents like luteolin and wogonin as potential therapeutic agents. Additionally, her work extends to exploring CNS toxicity of chemotherapeutics, marine functional foods, metabolic syndromes, and the cross-talk between central nervous and cardiovascular systems.

Awards and Recognitions

Ms. Shivani Chib has received numerous awards and recognitions throughout her career, including Best Working Model Award, Best Poster Awards at national and international conferences, and the prestigious GPAT fellowship. She has been awarded multiple international travel grants, including from the Movement Disorder Society and the Anusandhan National Research Foundation, enabling her to present her work globally, including at conferences in the USA and Japan. She has also received certificates of excellence in peer reviewing from Springer Nature and BP International. Her innovation in neuroscience is further highlighted by her registered patents on novel laboratory apparatuses, reflecting her inventive approach to experimental pharmacology.

Publications

Ms. Shivani Chib has published widely in reputed international journals, with her contributions cited in several scholarly works. Selected publications include:

Title: Unveiling the interplay of AMPK/SIRT1/PGC-1α axis in brain health: Promising targets against aging and NDDs
Journal: Ageing Research Reviews
Published on: 2024
Citation: 49

Title: Manganese and related neurotoxic pathways: A potential therapeutic target in neurodegenerative diseases
Journal: Neurotoxicology and Teratology
Published on: 2022
Citation: 35

Title: Unlocking the therapeutic potential of natural stilbene: exploring pterostilbene as a powerful ally against aging and cognitive decline
Journal: Ageing Research Reviews
Published on: 2023
Citation: 21

Title: Treatment of diabetic complications: do flavonoids holds the keys?
Journal: Critical Reviews in Food Science and Nutrition
Published on: 2024
Citation: 16

Title: Paradigms and success stories of natural products in drug discovery against neurodegenerative disorders (NDDs)
Journal: Current Neuropharmacology
Published on: 2024
Citation: 15

Title: Microbiota-brain-gut-Axis relevance to Parkinson’s disease: potential therapeutic effects of probiotics
Journal: Current Pharmaceutical Design
Published on: 2022
Citation: 11

Title: Role of flavonoids in mitigating the pathological complexities and treatment hurdles in Alzheimer’s disease
Journal: Phytotherapy Research
Published on: 2025
Citation: 10

Conclusion

Ms. Shivani Chib has established herself as a promising woman researcher in pharmacology through her strong academic background, impactful publications, innovative patents, and global recognitions. Her work in exploring the therapeutic applications of phytoconstituents against neurodegenerative disorders has the potential to open new pathways for safer and more effective treatments. With her commitment to excellence, interdisciplinary approach, and growing global presence, she exemplifies the qualities of a future leader in pharmacological sciences. She is therefore highly deserving of the Women Researcher Award, which would further empower her to continue contributing to scientific progress and global healthcare solutions.

Prabhat Singh | Pharmacology | Excellence in Research

Dr. Prabhat Singh | Neuroscience | Excellence in Research

Faculty of Pharmacy, Swami Vivekanand Subharti University | India

Dr. Prabhat Singh, a seasoned academic and researcher in the field of Pharmacology, currently serves as an Associate Professor at Kharvel Subharti College of Pharmacy, Swami Vivekanand Subharti University, Meerut. Born on July 8, 1988, Dr. Singh holds a B. Pharm., M. Pharm. (Pharmacology), and a Ph.D. His passion lies in advancing pharmaceutical education and scientific R&D. His academic dedication and research acumen have established him as a prominent figure in neuropharmacological research.

Professional profile👤

Google Scholar

ORCID

Scopus

Strengths for the Awards✨

Dr. Prabhat Singh demonstrates a consistent and impactful research trajectory in the field of Neuropharmacology, Vascular Dementia, and Physiological Brain Conditioning. With over 22 peer-reviewed publications, several in high-impact journals such as Neurochemical Research, Current Neurovascular Research, and Central Nervous System Agents in Medicinal Chemistry, his work reflects both depth and innovation.

  • He has published research with a total international impact factor exceeding 31.8, an h-index of 9, and over 300 citations, highlighting growing academic recognition.

  • His exploration of novel pharmacological targets in ischemia-reperfusion brain injury and morphine withdrawal syndromes represents translational value in therapeutic strategies.

  • Dr. Singh has contributed significantly to scholarly literature through book publications (4 authored books), book chapters (3 in Nova Science Publishers, USA), and 6 IPRs on innovative healthcare technologies, including AI-powered medication systems and neurodegenerative disease detection devices.

  • As a Ph.D. supervisor to six scholars and mentor to eight M.Pharm students, he has actively nurtured the next generation of pharmaceutical researchers.

🎓 Education

Dr. Singh completed his Ph.D. in Pharmacology from Dr. APJ Abdul Kalam Technical University, Lucknow in 2022. He earned his M. Pharm. from Mahamaya Technical University, Noida with an impressive 81.78% in 2013 and his B. Pharm. from Uttar Pradesh Technical University in 2011 with 73.19%. His foundational education was completed under the Uttar Pradesh Board, achieving consistent academic performance. He is also a GPAT qualifier (2011) and actively contributes to university committees.

👨‍🏫 Experience

Dr. Singh has over a decade of teaching experience. Since February 2023, he has been working as an Associate Professor at Kharvel Subharti College of Pharmacy. Previously, he served as Assistant Professor at the same institution from 2016 to 2023 and at Kalka Institute for Research and Advanced Studies from 2013 to 2016. Additionally, he has industrial experience as a Product Sales Representative with Dr. Reddy’s Laboratories. He has guided 08 M. Pharm theses and is currently supervising 06 Ph.D. scholars.

🔬 Research Interests On Pharmacology

Dr. Singh’s research interests are deeply rooted in Neuropharmacology, with specific focus on vascular dementia, neurotoxicity, and physiological brain conditioning. His doctoral research involved novel pharmacological interventions during experimental ischemia-reperfusion brain injury. His work integrates behavioral neuroscience and biochemical analysis to explore therapeutic pathways in brain disorders.

🏆 Awards & Achievements

Dr. Singh is a committed academic with a strong track record of publication and intellectual property. He has authored four books, contributed to multiple book chapters published by Nova Science Publishers, and published six IPRs including innovations in AI-based medication systems and neurodegenerative disease detection devices. His cumulative journal impact factor exceeds 31.8, with an h-index of 9 and over 300 citations.

📚 Publications

  • Neuroprotective effects of agomelatine and vinpocetine against chronic cerebral hypoperfusion induced vascular dementia
    Authors: S Gupta, P Singh, B Mohan Sharma, B Sharma
    Year: 2015
    Citations: 73

  • Melatonin receptor and KATP channel modulation in experimental vascular dementia
    Authors: P Singh, S Gupta, B Sharma
    Year: 2015
    Citations: 45

  • Modulation of transient receptor potential vanilloid subtype 1 (TRPV1) and norepinephrine transporters (NET) protect against oxidative stress, cellular injury, and vascular …
    Authors: S Gupta, B Sharma, P Singh, B Mohan Sharma
    Year: 2014
    Citations: 40

  • Neuroprotective effects of nicorandil in chronic cerebral hypoperfusion-induced vascular dementia
    Authors: S Gupta, P Singh, B Sharma
    Year: 2016
    Citations: 26

  • Reversal in cognition impairments, cholinergic dysfunction, and cerebral oxidative stress through the modulation of ryanodine receptors (RyRs) and cysteinyl leukotriene-1 …
    Authors: P Singh, B Sharma
    Year: 2016
    Citations: 25

  • Selective serotonin-norepinephrine re-uptake inhibition limits renovascular-hypertension induced cognitive impairment, endothelial dysfunction, and oxidative stress injury
    Authors: P Singh, B Sharma
    Year: 2016
    Citations: 23

  • In vivo and in vitro attenuation of naloxone-precipitated experimental opioid withdrawal syndrome by insulin and selective KATP channel modulator
    Authors: P Singh, B Sharma, S Gupta, BM Sharma
    Year: 2015
    Citations: 22

  • Antiepileptic activity of aqueous extract of Tricosanthes dioica Roxb
    Authors: SG Prabhat Singh, Vipin K Garg, Pramod K Sharma
    Year: 2012
    Citations: 13

  • Plant bioactive compounds and their mechanistic approaches in the treatment of diabetes: a review
    Authors: Anshika, RK Pandey, L Singh, S Kumar, P Singh, M Pathak, S Jain
    Year: 2022
    Citations: 12

  • Antagonism of endothelin (ETA and ETB) receptors during renovascular hypertension-induced vascular dementia improves cognition
    Authors: P Singh, S Gupta, B Sharma
    Year: 2016
    Citations: 12

🧩 Conclusion

Dr. Prabhat Singh exemplifies academic excellence and research innovation in pharmacological sciences. With deep engagement in neuropharmacology, substantial teaching contributions, groundbreaking IPRs, and impactful publications, he continues to push the frontiers of pharmaceutical research and education. His commitment to scientific inquiry and student mentorship makes him a highly deserving candidate for this prestigious research award.